Product Detail

2017 Psychopharmacology 2-Day Conference
DVD Video
$299.99 USD
Now Available For Preorder
Product Details
Format:
DVD Video - 4+ hours
Details:
Multi-disc video recording with electronic manual and instructions
Author:
PERRY W BUFFINGTON, PHD, MS
Publisher:
PESI Inc.
Copyright:
9/14/2017 - Available Now for Pre-Order
CE Available:
Yes, See CE credit tab for complete continuing education details
Product Code:
RNV048500
Objectives
  1. Analyze the historical antecedents of psychopharmacological products and their relation to today’s psychotropic medications.
  2. Designate the mechanism of action of today';s psychotropic medications.
  3. Breakdown the process of medication selection and receptor activation/blocking for specific disorders.
  4. Communicate the side effects including nutritional, cognitive, sexual, and behavioral associated with psychotropic medications.
  5. Evaluate options for clients including medications and/or psychotherapy.
  6. Specify how medications are chosen for mood disorders and specific patient characteristics.
  7. Compile medication treatment options for ADHD.
  8. Determine the unique medication considerations for geriatric clients.
  9. Determine acute and chronic pain and methods of treatment.
  10. Analyze future trends, including preventing side effects vs. managing side effects.
  11. Establish common ethical issues specifically germane to the modern practice of clinical psychopharmacology.
  12. Apply traditional standards (autonomy, beneficence, nonmaleficence, confidentiality, veracity) of ethical behavior to issues peculiar to the practice of clinical psychopharmacology.
  13. Explore specific ethical issues and their resolve to the everyday practice of clinical psychopharmacology.
Outline

DAY ONE

PSYCHOPHARMACOLOGY

  • Historical antecedents of modern psychopharmacology
  • Diagnostic issues
  • Clarification of terms
  • Drug metabolism concepts: pharmacokinetics & pharmacodynamics
  • Drug mechanism of action
  • Placebo & Nocebo
  • Pharmacotherapy vs. Pharmacotherapy
  • Developing highly effective collaborations with prescribers

DEPRESSIVE DISORDERS

  • Biogenic Amine, Cortisol, Down-Regulation, & Neurotropic Hypotheses
  • Neurochemistry of depression
  • Types of anti-depressants
  • Preventing side effects
  • Tardive Dysphoria: real or imagined?

ANXIETY DISORDERS & OBSESSIVE COMPULSIVE DISORDERS & TRAUMA RELATED DISORDERS

  • Neurochemistry of anxiety
  • GAD, panic disorders, phobias
  • OCD
  • PTSD
  • Physiological interventions
  • Anti-anxiety medications
  • Anti-depressants
  • Non-pharmacologic options
  • Benzodiazepines: risks and benefits
  • Preventing side effects

BIPOLAR DISORDERS

  • Neurochemistry
  • The Bipolar Spectrum & DSM-5® Changes
  • Mood stabilizers
    • Lithium
    • Anti-convulsants & neuromodulators
  • Typical, atypical, & third-generation antipsychotics
  • Effective strategies for improving outcomes for clients

PSYCHOTIC DISORDERS/ SCHIZOPHRENIA

  • Neurochemistry of psychosis and schizophrenia
  • Antipsychotic Medications:
    • First generation (typical)
    • Second generation (atypical)
  • Managing side effects
    • Extrapyramidal symptoms and TD
    • Metabolic problems- what blood tests are needed and when
    • Preventing Diabetes Mellitus
  • Recognizing hyperprolactinemia- and why you need to know
  • Use of atypical antipsychotics for multiple disorders

DAY TWO

ATTENTIONAL DISORDERS

  • Differential diagnosis
  • Neurochemistry of ADHD
  • Treatment controversies
  • Substance abuse and ADHD
  • Stimulant medications
  • Non-stimulant options
  • Preventing side effects

SUBSTANCE ABUSE DISORDERS

  • Neurochemistry of addiction
  • Negative reinforcement & creation of habits
  • Alcohol
  • Caffeine
  • Nicotine
  • Cannabis
  • Opiates
  • PCP & Ketamine
  • MDMA (Ecstasy)
  • Energy vs. Chill Drinks
  • Over-the-counter & herbal psychopharmacology
  • Addiction treatments
  • Behavioral addictions

SPECIAL POPULATIONS

  • Specialized guidelines for geriatric patients
  • Dementia treatment
  • Slow vs. rapid metabolizers (genetic polymorphisms)

TREATING CLIENTS PAIN

  • Acute vs. chronic pain
  • Alternatives to pharmacology
  • Pain vs. depression: which comes first?

ETHICS & PSYCHOPHARMACOLOGY

  • High-risk pharmacology & psychopharmacology
  • Off-label use of medications
  • Prescribing for children
  • Elective psychopharmacology
  • Marketing of mental illness
  • Polypharmacy
  • Informed vs. uninformed consent
  • Patient & third party pressures
  • Professional boundaries
  • Ethics associated with medical errors
  • Role of placebo

FUTURE TRENDS

  • Change of mind: preventing vs. managing side effects
  • Medicalization of normal
  • Computer assisted devices
  • New meds, new diagnoses, new theories, new normal
  • Top 10 Medical Emergencies
  • Integrating psychotherapy with psychopharmacology
Author

PERRY W BUFFINGTON, PHD, MS

Perry Buffington, Ph.D., M.S., has worked for 20 years in the medical-consulting field before turning to teaching and writing. Dr. Buffington teaches psychopharmacology at the undergraduate and graduate levels for the University of Georgia, Georgia Southern University, and the Georgia School of Professional Psychology. He is chairman of the prestigious Florida Psychological Association’s Prescriptive Authority Committee and teaches seminars nationwide on minimizing psychopharmacological errors.

As the author of eight books (currently working on his first psychopharmacology text), his by-line has appeared in hundreds of periodicals including the Saturday Evening Post, USA Today, and Success. He is the former contributing editor for Delta Air Lines’ in-flight magazine, Sky, and served as a syndicated newspaper/web columnist for Universal Press. Additionally, he hosted his own radio show, syndicated nationally, by Envison Radio Networks.

Perry’s presentation style is engaging, a blend of education and entertainment; as a result, critics (and especially his students) applaud his ability to make complicated topics understandable and applicable – even useful!

Speaker Disclosures:

Financial: Perry Buffington is the President of Go-Buff Enterprises, Inc. He is a member of the psychology faculty, Franklin College of Arts & Sciences, The University of Georgia. Dr. Buffington receives a speaking honorarium from PESI, Inc.

Nonfinancial: Perry Buffington has no relevant nonfinancial relationship to disclose.
Continuing Education Credits

CE Information Coming Soon
Continuing education credit information is coming soon for this self-study package.

CEs may be available for select professions, as listed in the target audience. Hours will be dependent on the actual recording time. Please check with your state licensing board or organization for specific requirements.

There may be an additional fee for CE certificates. Please contact our Customer Service at 1-800-844-8260 for more details.

**Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards.

Audience
Addiction Counselors, Case Managers, Counselors, Marriage & Family Therapists, Nurses, Pharmacists, Psychologists, Social Workers, and other Mental Health Professionals